September 9, 2024 — The American College of Clinical Pharmacology is meeting in Bethesda this week. On the opening day, ACCP convened a symposium to address critical questions about how drugs work in people with obesity. What can we – industry, FDA, and scientists – do better? Because all too often, drug labels to guide safe prescribing are effectively […]
November 29, 2023 — It is time to translate words into action and fix the blind spot in drug trials and labeling for people with obesity. Every major obesity group in the U.S. issued this united call to action on Tuesday. This includes the ASMBS, Obesity Action Coalition, Obesity Medicine, Obesity Society, and STOP Obesity Alliance. It comes as […]
October 23, 2023 — It’s a “deficit of information” we should correct, says FDA Commissioner Robert Califf. He is speaking about the gap in information about how to correctly dose drugs for people living with obesity. Karen Weintraub, reporting for USA Today, tells us this gap might mean that doctors are prescribing the right drug at the wrong dose […]
